NeoStrata's Exuviance will be detailed to physicians by Ortho Dermatologics.
This article was originally published in The Rose Sheet
Executive Summary
NEOSTRATA/ORTHO EXUVIANCE MARKETING AND SALES ALLIANCE awards Johnson & Johnson's Ortho Dermatologics exclusive marketing and distribution rights to physicians for NeoStrata's 14-SKU nonprescription, poly hydroxy acid skin care line. NeoStrata retains marketing rights for Exuviance in U.S. retail channels and both retail and physician channels outside the U.S. The companies announced the agreement Feb. 28. Ortho will position the line as a direct-dispensing opportunity for physicians.